Matrix metalloproteinase −2, −9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension
International Journal of Cardiology Hypertension · 2020
DOI: 10.1016/j.ijchy.2020.100025 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiology Hypertension, 2020. Verfasst von Stella Stabouli und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1st Department of Pediatrics, Aristotle University of Thessaloniki, Hippokratio General Hospital, Thessaloniki, Greece. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Procter and Gamble.
Themen: Diabetes mellitus, Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND AND AIMS: Matrix metalloproteinases (MMPs) may contribute to the pathogenesis of arterial stiffness inducing extracellular matrix remodeling. We aimed to compare MMP-2 and -9 levels in children with chronic kidney disease (CKD), type 1 diabetes (without chronic kidney disease) and healthy control and to investigate associations of MMPs levels with cardiovascular risk factors and markers of arterial stiffness. METHODS: The study population included 33 CKD, 18 type 1 diabetes patients, and 24 healthy controls. MMP-2, MMP-9, office blood pressure, pulse wave analysis, and carotid-femoral pulse wave velocity (cfPWV) measurements were performed. RESULTS: MMP-2 levels were higher in the CKD compared to the diabetes and control groups (p < 0.05). MMP-9 levels did not differ among groups. In hypertensive individuals logMMP-2 independently associated with PWV z score (β = 0.744, 95%CI 0.105 to 2.921, p < 0.05) after adjustment for age, sex, GRF, and phosphate levels. Creatinine levels correlated positively with MMP-2 in the CKD (r = 0.39, p < 0.05) and negatively in the diabetes group (r = -0.72, p < 0.05). Cholesterol levels correlated with MMP-2 in the diabetes group (r = 0.70, p < 0.05). Phosphate levels correlated with MMP-2 level in the control group (r = 0.67, p < 0.05). In multivariate regression model adjusted for age and sex, including phosphate and GRF as covariates, only phosphate predicted logMMP-2 levels (β = 0.333, 95%CI 0.060 to 0.671, p < 0.05). CONCLUSIONS: MMP-2 associated with arterial stiffness in the presence of hypertension, while the role of MMP-9 is less clear in children with CKD or type 1 diabetes. Whether up-regulation of MMPs could predict poor outcomes in young high-risk patient groups need to be confirmed by future studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 1st Department of Pediatrics, Aristotle University of Thessaloniki, Hippokratio General Hospital, Thessaloniki, Greece.
- 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Hypertension-24h ABPM Center, Papageorgiou General Hospital, Thessaloniki, Greece.
Förderung
- Procter and Gamble
Zitieren
APA
Stabouli, S., Kotsis, V., Maliachova, O., Printza, N., Chainoglou, A., Christoforidis, A., Taparkou, A., Dotis, J., Farmaki, E., & Zafeiriou, D. (2020). Matrix metalloproteinase −2, −9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension. International Journal of Cardiology Hypertension. https://doi.org/10.1016/j.ijchy.2020.100025
Vancouver
Stabouli S, Kotsis V, Maliachova O, Printza N, Chainoglou A, Christoforidis A, et al. Matrix metalloproteinase −2, −9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension. International Journal of Cardiology Hypertension. 2020. doi:10.1016/j.ijchy.2020.100025
BibTeX
@article{Stabouli2020,
author = {Stabouli, Stella and Kotsis, Vasilios and Maliachova, Olga and Printza, Nikoleta and Chainoglou, Athanasia and Christoforidis, Athanasios and Taparkou, Anna and Dotis, John and Farmaki, Evangelia and Zafeiriou, Dimitrios},
title = {Matrix metalloproteinase −2, −9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension},
journal = {International Journal of Cardiology Hypertension},
year = {2020},
doi = {10.1016/j.ijchy.2020.100025}
}
EUVIMED